US Stock MarketDetailed Quotes

CLYM Climb Bio

Watchlist
  • 3.220
  • +0.180+5.92%
Close Nov 27 16:00 ET
  • 3.200
  • -0.020-0.62%
Post 16:20 ET
216.46MMarket Cap-1894P/E (TTM)

Climb Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Climb Bio Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--2022/Q20.000 / 0.000--
--2022/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Climb Bio Earnings Reports

  • Climb Bio | 8-K: Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights

    Nov 12 16:42 ET

  • Climb Bio | 10-Q: Q3 2024 Earnings Report

    Nov 12 16:03 ET

  • Eliem Therapeutics | 8-K: Eliem Therapeutics Reports Second Quarter Financial Results

    Aug 14 06:16 ET

  • Eliem Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 14 06:11 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data